Corbus enters amended employment agreements with CEO and CFO; base salaries $622,804 and $463,455

Corbus Pharmaceuticals Holdings, Inc.

CEO Yuval Cohen's 2-year agreement: base salary $622,804, bonus target up to 60% of base.
CFO Sean Moran's 2-year agreement: base salary $463,455, bonus target up to 40% of base.
Change-in-control severance: CEO 24 months salary, CFO 18 months; plus accelerated equity vesting.
Non-compete (6 months) and non-solicitation (12 months) apply, conditional on severance.
Agreements expire April 10, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.